NEW YORK, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dow Inc. ("Dow" or "the Company") (NYSE:DOW). Investors who purchased Dow securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/DOW. Investigation Details […]
NEW YORK, NY / ACCESS Newswire / August 1, 2025 / Avanza Capital Holdings is proud to announce that its outside general counsel, Anthony C. Varbero, was prominently quoted in Bloomberg Law’s midyear report on securities class actions, published in partnership with Cornerstone Research and Stanford Law School’s Securities Class Action Clearinghouse. AI, Big-Dollar Suits
NEW YORK CITY, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Charter Communications, Inc. ("Charter" or "the Company") (NASDAQ:CHTR). Investors who purchased Charter securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CHTR.
NEW YORK CITY, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novo Nordisk A/S ("Novo Nordisk" or "the Company") (NYSE:NVO). Investors who purchased Novo Nordisk securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s
NEW YORK, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Barnes & Noble Education, Inc. ("Barnes & Noble" or "the Company") (NYSE:BNED). Investors who purchased Barnes & Noble securities are encouraged to obtain additional information and assist the investigation by
NEW YORK CITY, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nutex Health, Inc. ("Nutex" or "the Company") (NASDAQ:NUTX). Investors who purchased Nutex securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NUTX.
NEW YORK CITY, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Molina Healthcare, Inc. ("Molina" or "the Company") (NYSE:MOH). Investors who purchased Molina securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/MOH.
NEW YORK, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Telix Pharmaceuticals Limited ("Telix" or "the Company") (NASDAQ:TLX). Investors who purchased Telix securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/TLX. Investigation
NEW YORK CITY, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lockheed Martin Corporation ("Lockheed" or "the Company") (NYSE:LMT). Investors who purchased Lockheed securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/LMT.
NEW YORK CITY, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Replimune Group, Inc. ("Replimune" or "the Company") (NASDAQ:REPL). Investors who purchased Replimune securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/REPL.